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The immune response of mice infected with Trypanosoma cruzi ( the 
causative agent of Chagas' disease) has been extensively studied, and it has 
been demonstrated tha t changes in environmental temperature can 
influence the resistance of infected mice to the parasite. In particular, 
several investigators have demonstrated an increased resistance to T. cruzi 
infection when infected mice are maintained at 36°C. This increased 
resistance is reflected in decreased parasitemias and increased longevity. 
In addition, this enhanced resistance has been shown to be an 
immunological phenomenon. CD4+ T cells play a very important role in 
immune responses to parasit ic infections through the secretion of 
cytokines. To explore a possible role for CD4+ T cells in this enhanced 
resistance to parasitic infection, anti-CD4 monoclonal antibody was used to 
deplete CD4+ T cells prior to infection. Parasitemia and mortality of mice 
were monitored under different environmental conditions. The results of 
this experiment indicate that 1) CD4+ T cells do play a role in this 
temperature related resistance to the parasite; 2) CD4+ T cells were 
particularly necessary early in infection for mice maintained at higher 
temperature to establish a protective resistance to T. cruzi\ 3) enhanced 
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resistance to T. cruzi at elevated temperature also involves CD4+ T cell 
independent pathways; 4) Elevated temperature may have an enhancing 
effect upon the activity of CD4+ T cells. 
vi 
INTRODUCTION 
The role of CD4+ T cells in parasitic infection 
After a host is infected by a parasite, a variety of different immune 
responses can be invoked. Certain subsets of T lymphocytes that can secrete 
distinct patterns of cytokines play a major role in the regulation of these 
responses. 
The CD4+ T cell is one of the major subsets of mature T cells. These 
cells bear a specific surface marker, the CD4 molecule, which is a 
glycoprotein of approximately 55 kilodalton (ED) (Kuby, 1992). CD4+ T cells 
are also called T helper cells, these cells play a key role in the regulation of 
the immune response by secreting different cytokines. 
The CD4+ T cells can be further divided into two major phenotypic 
subsets according to the pattern of their cytokines, TH1 and TH2 (Mosmann 
et al., 1986). TH1 cells secrete interleukin 2 (IL-2), interferon-y (IFN-y), and 
lymphotoxin (LT). In contrast, the TH2 cells secrete IL-4, IL-5, IL-6, and IL-
10. Both TH types express IL-3, granulocyte-macrophage colony-
stimulating factor (GM-CSF, preproenkephalin (ppENK), tumor-necrosis 
factor (TNF) and three members of the macrophage inflammatory protein 
family (Cherwinski et al., 1987). 
CD4+ T cells can serve as helper cells for both antibody synthesis and 
cell mediated responses. The different cytokine pat terns lead to very 
different functions of T cells, and these properties have been extensively 
reviewed (Mosmann and Coffman, 1989). They are involved in the activation 
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of macrophages, delayed-type hypersensitivity (DTH), and stimulation of 
the proliferation of both B lymphocytes and T lymphocytes. It is clear that 
the help for B-cell antibody synthesis is provided primarily by TH2 cells. 
TH2 cytokines such as IL-4, IL-5 and IL-6, stimulate various aspects of B-
cell growth and differentiation. TH1 clones can also provide help for B-cell 
antibody secretion by secreting IL-3. However, TH1 cells play a major role in 
cell-mediated immune responses by producing IL-2 which can activate T 
lymphocytes to proliferate. Interferon-y which is a major macrophage 
activating factor that can induce toxoplasmacidal activity in macrophages 
and mononuclear cells is also synthesized by TH1 cells. It is very 
interesting to immunologists who study infectious diseases that the TH1 and 
TH2 cells can cross-regulate each other by the release of special cytokines. 
IFN-y has suppressive effects on TH2 cells, and IL-10 has suppressive 
effects on TH1 cells(Cher & Mosmann, 1987; Cherwinski et al., 1987; 
Fiorentino et al., 1989; Bacchetta et al., 1990; Abbas, et al., 1991; Scott & 
Kaufman, 1991; Cox and Liew, 1992). 
A number of studies have demonstrated that CD4+ T lymphocytes are 
active participants in mechanisms that modulate both enhancement and 
resis tance to infection with various parasi t ic organisms including 
Leishmania sp., Trypanosoma cruzi, Schistosoma mansoni, and 
Pneumocystis carinii (reviewed by Sher and Coffman, 1992). In murine 
toxoplasmosis, CD4+ T cells participate in protection against death during 
acute infection and are impor tant modulators of pathogenesis of 
toxoplasmic encephalitis in chronically infected animals (Araujo, 1991). 
Many cells of the immune system are under CD4+ T cell control; 
therefore, inhibition of the humoral and cell-mediated immune responses 
and induction of tolerance to some nonreplicating antigens may be achieved 
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by t reatment of mice with a rat monoclonal antibody specific for mouse 
CD4+ (GK1.5). Injection of GK1.5 followed by immunization of mice with a 
nonreplicating antigen of T. cruzi resulted in an almost complete 
abrogation of the antibody and cell-mediated immune responses to antigens 
of the paras i t e even when they were mixed with the potent 
immunomodulator saponin. Moreover, the injected and immunized mice 
completely failed to develop resistance to a challenge infection with T. cruzi 
blood-form trypomastigotes. It was also shown that treatment with GK1.5 
effectively inactivated the capacity of CD4+ T cells to recognize T. gondii 
antigens and induce development of humoral and cell-mediated immune 
responses in spite of the continuous presence of parasite antigen provided by 
multiplying organisms (Araujo, 1991). 
Sadick and coworkers (1990), in studies with BALB/c mice susceptible 
to the intracellular parasite Leishmania major, demonstrated tha t 
treatment with GK1.5 monoclonal antibody did not directly kill or prevent 
IFN-y producing cells from proliferating but did greatly reduce the ability of 
the mice to produce IFN-y. This result suggests that in the model with 
BALB/c mice and L. major, IFN-y-producing cells may be dependent on a 
critical subset of CD4+ T cells to become functional cells. Experiments 
which demonstrated that significantly less inflammation occurred in brains 
of mice infected with T. gondii and treated with GK 1.5 may be explained by 
a similar mechanism, since a major role for IFN-y in the pathogenesis of 
toxoplasmic encephalitis has been recently demonstrated (Sadick et al., 
1990). 
A mouse model system was developed and used by Araujo (1992) to 
study the effects of in vivo depletion of CD4+ T cells and/or inhibition of the 
protective activity of IFN-y on the effectiveness of drug therapy for 
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toxoplasmosis. Infection of mice with a lethal inoculum of Toxoplasma 
gondii cysts followed by treatment with the hygroxynaphthoquinone 566c80 
or with sulfadiazine result in 100% survival, whereas untreated controls 
experienced 100% mortality. Administration of anti-IFN-y antiserum 
resulted in early death of untreated mice and in 30% mortality in those 
treated. Sulfadiazine and hydroxynapthoquinone 566c80 were unable to cure 
toxoplasmosis when CD4 + T cells were depleted by injection of mAb to CD4+ 
T cells. These results indicate that successful treatment of toxoplasmosis 
depends on the status of the immune system, particularly the status of CD4+ 
T cells. These results also illustrate the crucial role tha t a functional 
immune system may play in enhancing the efficacy of therapeutic agents 
against parasites (Araujo, 1992). 
Cross-regulation of TH1 and TH2 responses during parasitic infection 
Parasitic infection is frequently accompanied by a downregulation in 
host cell-mediated immunity. Recent studies suggest that this modulation 
of CD4+ T cells and effector cell function can at least in part be attributed to 
the action of a set of inhibitory cytokines produced by T lymphocytes as well 
as by a number of other cell types. The best characterized of these inhibitory 
lymphokines are IL-4, IL-10 and TGF-b. Both IL-4 and IL-10 are produced 
by the TH2 subset of CD4+ T cells but not TH1 cells. The TH2 subset 
dominates in many situations of chronic or exacerbated parasitic infection 
and is thought to suppress TH1 function as a consequence of the cross-
regulatory activity of these two cytokines. This hypothesis is supported by 
experiments demonstrating that mAb-mediated neutralization of IL-10 
reverses suppressed IFN-y responses and/or disease susceptibility in mice 
with parasitic infections. In vivo neutralization of TGF-b has been reported 
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to increase host resistance to parasite challenge (Gajewski et al., 1989; 
Mosmann et al., 1986; Mosmann & Coffman, 1989; Scott et al., 1989; Scott, 
1991; Peltz, 1991). 
Unlike the bacterial and viral infections which tend to be resolved 
relatively quickly (cure or death), many parasitic infections persist for long 
periods and involve high antigen loads. The immune system is stimulated 
strongly and chronically, and a variety of extreme responses will be seen. 
There are a number of parasites that provoke an extremely strong TH2-like 
response involving not only the TH2 cytokines but also high IgE and 
eosinophil levels. There are also some parasites that induce a very strong 
DTH response with the absence of significant antibody or IgE production. It 
is now believed that subsets of CD4+ T lymphocytes play a key role for 
determining which response will be aroused (Beaman et al., 1992; Sher et 
al., 1992). 
Studies in which mice have been treated with anti-IL-4 and anti-IL-5 
in vivo have shown that the high levels of parasite-specific antibody 
(especially IgE) and also high eosinophil levels in Nippostrongylus 
brasiliensis (Bb) infection are due to IL-4 and IL-5, respectively. When 
splenic T cells, lung, or mesenteric lymph node T cells are obtained from 
infected animals and restimulated with polyclonal stimuli in tissue culture, 
very high levels of the TH-2 cytokines IL-4, IL-5, and IL-10 are produced; 
often there is a reduction in the ability of these cells to produce IL-2 and IFN-
y. When anti-IL-10 antibody is added to the in vitro culture system during 
the st imulation of normal mouse splenocytes, there is a moderate 
enhancement of the amount of IFN-y secreted. However, if anti-IL-10 
antibodies are added to the cultures from parasite-infected animals, there is 
a greater increase in the amount of IFN-y produced, suggesting that the 
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high levels of IL-10 produced during the culture period are suppressing the 
synthesis of IFN-g in the same culture. (Sher et al., 1992; Sher et al., 1991; 
Fiorentino et al., 1991a) 
During infection by Schistosoma mansoni, a strong immune response 
develops after parasite production of eggs. The egg antigens induce a very 
powerful TH2-like response involving high levels of IL-4, IL-5 and IL-10. 
Antigen stimulation in culture does not induce significant levels of IFN-y 
secretion. However, if anti-IL-10 antibodies are added to these cultures, high 
levels of IFN-y secretion are observed, suggesting that the IL-10 produced 
during the culture is able to substantially inhibit the synthesis of IFN-y in 
the same culture, (reviewed by Mosmann et al., 1991) 
Unanswered questions pertaining to CD4 + T cells in parasitic infection 
CD4+ T cells may play the key role in the immune system in 
regulating the immune response. It has been shown tha t in T. cruzi 
infection both CD4+ and CD8+ T cells are necessary during the early acute 
phase of infection but contribute less to immune resistance as the antibody 
response builds. Stimulation of the T-cell compartment also may induce 
responses which contribute to pathogenesis. (Tarleton, 1991a) 
Several unanswered questions remain concerning CD4+ T cells. 
Which cell types mediate the initial decision of the direction of TH cell 
differentiation? What is the nature of the signals that induce selective 
differentiation? Even though several cytokines have already been implicated 
in the differentiation process, it is very likely tha t different antigen 
presenting cells (APC) are also involved. Such APC subsets could directly 
influence the type of TH cell obtained, or the choice could be regulated by 
cytokines secreted by third-party cells such as mast cells, NK cells or other T 
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cells. It is very likely that the mechanisms of this choice will be multiple, 
redundant and substantially interregulated. 
Because quantitative variations in cytokines exist between cells from 
the same subset of CD4+ T cells, investigators have hypothesized that TH 
cells might be further subdivided. Another interesting quantitative question 
is whether T-cell activation is an "all-or-none" phenomenon, or whether 
different amounts can be released in response to quantitatively or 
qualitatively different signals. This question is particularly important 
because of the suggestion of directional release of cytokines. TH cells, when 
maximally stimulated, secrete sufficient amounts of cytokines(such as IL-3, 
IL-4 and IL-5) to stimulate more than 1000 target cells; thus, directional 
release would not be expected to be significant unless smaller amounts of 
cytokine were secreted under some circumstances. (Tarleton, 1991a). 
The final question is the possible existence of memory cells for 
effector function as well as specificity. Recent evidence suggests that long-
term memory TH cells may produce predominantly or exclusively IL-2 
when first restimulated. Under many circumstances, it would be useful for 
the memory response to reexpress the same set of effector functions as those 
expressed during the primary response. It is possible tha t long-term 
memory cells are in fact uncommitted, so that the differentiation to effector 
phenotypes occurs under similar regulation to that of the primary response. 
Alternatively, the memory TH population, although expressing only IL-2 
when initially stimulated, nevertheless may still be committed to the 
production of a particular set of cytokines that will be expressed on repeated 
stimulation. (Mosmann et al., 1991) 
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The suppression of immune responses dnringTrypanosoma cruzi infection 
Trypanosoma cruzi is the etiologic agent of American 
Trypanosomiasis or Chagas' disease and it is believed to infect between 12-40 
million people in endemic regions of Central and South America (Kuhn, 
1981; Swendel & Gonzaga, 1993). 
The protective immune response to T. cruzi infection in mice and in 
humans is known to involve the combined effects of a number of different 
immune mechanisms, including the production of antibodies, helper and 
effector functions of CD4+ T cells, activity of CD8+ T cells, and the 
production of cytokines. (Cunningham and Kuhn, 1980; Trischman, 1983; 
Hontebeyrie-Joskowicz, 1991) 
Although various effector mechanisms are induced to respond to 
infection with T. cruzi, a significant nonspecific suppression of both 
humoral and cell-mediated responses also develops in infected mice 
(Gonzalves da Costa et al., 1984; Plata, et al., 1987). Suppression of parasite-
specific responses has also been demonstrated and is thought to reduce the 
resistance of an infected host to T. cruzi (Coffman & Mosmann, 1991). 
Tarleton and Kuhn (1985) used T. cruzi conjugated to the hapten 
trinitrophenyl (TNP; the conjugated preparation is designated TNP-TC) in 
the Mishell-Dutton culture system to measure the direct plaque-forming cell 
(DPFC) response of non-infected and T. cruzi- infected mice to TNP-TC. The 
anti-hapten B-cell responses reflected the activity of carrier-specific T-helper 
cells to T. cruzi. The response of spleen cells from infected mice to TNP-TC 
was not found to be significantly higher (and was often lower) than that of 
normal spleen cells. These results suggest t ha t parasite-specific 
suppression of T-helper-cell activity could be occurring during infection. 
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The addition of exogenous interleukin-2 (IL-2), or the replacement of 
resident macrophages with normal macrophages in in vitro assays, 
increased the responsiveness of spleen cells from infected mice. From these 
observations, it seems that the initial priming to T. cruzi during infection 
may not be sufficient to expand the parasite-specific T-helper-cell population 
and tha t perhaps the same suppressor mechanisms which down-regulate 
the reaction to heterologous antigens might also be suppressing the 
response of T. cruzi-specific T-helper cells.(Tarleton and Kuhn, 1985) 
Experimental observations strongly suggest that T cells control, at 
least in part, the parasitemia and resistance of mice to acute infection. 
Neonatally thymectomized or nu/nu mice present higher parasitemia and 
less resistance to acute infection than do normal mice. In vivo t reatments 
with monocolonal antibodies against T cell surface markers indicate that 
both CD4+ and CD8+ T cells may play a role in determining resistance in 
the acute phase of infection by controlling parasitemia and antibody 
production. In the acute phase, passive transfer of T. cruzi specific T-cell 
clones has provided protection against acute phase infection.(Cunningham 
& Kuhn, 1980; Hontebeyrie-Joskowicz, 1991; Minoprio et al., 1989; Tarleton, 
1990) 
The role of CD4+ T lymphocytes inT. cruzi infection 
As in other parasitic infection, the CD4+ T cell also plays a key 
regulatory role in T. cruzi infection though the secretion of cytokines. 
Interleukin-2 (IL-2) is the cytokine secreted by TH1 T lymphocytes. It 
is a single polypeptide which has a molecular weight of approximately 
15.5KD (Kuby, 1992). Interleukin-2 has been the focus of many studies on T. 
cruzi infection both because of its central role as the primary T cell growth 
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factor and because its production is severely suppressed during the acute 
phase of infection. Exogenous IL-2 can alter the immune responsiveness of 
lymphocytes from T. cruzi-infected mice as well as the course of infection 
but cannot completely overcome immunosuppression or resul t in 
parasitological cure in the mouse model of T. cruzi infection. The cellular 
and molecular mechanisms of IL-2 suppression in T. cruzi infection are not 
yet clear. (Tarleton, 1991b; Peltz, 1991) 
IL-2 production in general is known to be regulated primarily at the 
transcriptional level, and the correlation of depressed IL-2 production with 
low to absent IL-2 mRNA in mitogen-stimulated T cells from T. cruzi-
infected mice suggests that this is the probable level of regulation in T. cruzi 
infection (Tarleton, 1991b). 
Interferon-y (IFN-y) is also secreted by TH1 cells, and it has been 
identified as the major macrophage activating factor. This cytokine is also 
produced by CD8+ T lymphocytes, but in significantly smaller quantities 
compared with CD4+ T lymphocytes ( Mosmann & Moore, 1991). 
Surprisingly, it was found that the major producers of IFN-y in the spleens 
of T. cruzi-infected mice are Thy-1 bearing CD4- CD8- cells. The TH1 cells in 
T. cruzi- infected mice are suppressed with respect to IL-2 production and 
do not contribute to the abundant production of IFN-y. (Tarleton, 1991b) 
During T. cruzi infection, another dramatic change in cytokine 
production in mice is the elevated level of IFN-y. Throughout T. cruzi-
infection, the ability of splenic T cells to make IFN-y remains at or above 
that of spleen cells from normal mice. In addition, spleen cells from T. 
cruzi -infected mice produce IFN-y in response to parasite antigens as well 
as mitogens. Serum levels of IFN-y are also high as are IFN-y mRNA levels 
and spontaneous IFN-y production in unstimulated spleen cells from 
11 
acutely infected mice. Serum levels of IFN-y drop significantly after 18-20 
days of infection, at the time when IL-2 production is minimal. It seems that 
the IFN-y is significantly affected by IL-2 since the mice treated with 
exogenous IL-2 have obviously enhanced IFN-y levels. The macrophages 
activated by IFN-y treatment are able to efficiently kill or inhibit the growth 
of intracellular forms of both parasites in vitro and in vivo, and the 
production of nitrous oxide has been shown to be important for these effects 
(Tarleton, 1991b; Sher et al., 1992; Scott, 1991). 
Interleukin-4 is primarily secreted by TH2 CD4+ T cells, but it is also 
secreted by mast cells and basophils. IL-4 has multiple functions in the 
immune system. It can induce the switching of B cells to IgE secretion. 
This effect is mediated at the DNA level. IL-4 induces the transcription of 
the e constant region and subsequently the recombination of the VDJ region 
from the m to the e constant region. IL-4 also induces switching to IgGl 
production(Gajewski et al., 1989; Sadick et al., 1990; Mosmann et al. 1991). 
In Trypanosoma cruzi infection, IL-4 has been potential B-cell stimulating 
activity as do IL-5 and IL-6. Most research has focused on the ability of IL-4 
to play a role in the cross-regulation of TH1 and TH2 responses during 
parasitic infection. The major effect for down-regulation of cell mediated 
immunity is that IL-4 can suppress the differentiation of TH1 and inhibit the 
activation of macrophages (Sher et al., 1992). 
IL-10 has been isolated from TH2 culture supernatants based upon its 
activity in inhibiting the secretion of cytokines by TH1 cells when stimulated 
with spleen cells plus antigen. IL-10 is now known to exert a direct effect on 
antigen-presenting cell in inhibiting the antigen presentation to TH1 cells. 
The native molecular weight of IL-10 is approximately 16 to 20 KD, and it 
often appears as a homodimer (Mosmann et al., 1991). 
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With the availability of recombinant IL-10, many other functions have 
also been discovered. These activities are similar to those of IL-4. 
Specifically, it can inhibit IFN-y synthesis by TH1 cells. Both IL-4 and IL-10 
also inhibit the synthesis of IL-1, IL-6 and TNF-a by macrophages. In a 
study in which spleen cells were used as antigen-presenting cells, it was 
found that IL-10 was able to significantly inhibit the synthesis of IFN-y by 
various CD8+ clones. (Mosmann et al, 1991; Sher et al., 1992; Sher et al., 
1991; Fiorentino et al, 1991b) 
Coffman & Mosmann (1991) found tha t IL-10 does not play a 
significant regulatory role in Leishmaniasis. However, in T. cruzi 
infection, IL-10 has an important regulatory effect. Anti-IL-10 treatments 
rendered susceptible mice resistant to T. cruzi. A similar down-regulation 
of cell mediated immunity during infection with T. gondii has also been 
found. 
In addition to the above cytokines, there is one other important 
cytokine that should be mentioned: Transforming Growth Factor-b (TGF-b). 
This cytokine is secreted by platelets, macrophages and T and B 
lymphocytes. TGF-b has a broad anti-proliferative effect on both B and T cells 
but can apparently influence CD4 + T cell responses by inducing the 
development of memory cells from resting precursor populations. (Silva et 
al., 1991; Sher et al, 1992) 
The therapeutic effects of elevated temperature during parasitic infection 
The value of fever as a clinical sign has been widely reported since 
ancient time, and in the past the presence of fever was often regarded as 
favorable to the patient's survival. Artificial fever was used to combat 
intractable chronic infections in the 1920s. Today it is recognized that fever 
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is a regulated rise in body temperature under central nervous system 
control. The central nervous system adjustments that lead to fever are 
stimulated by a pyrogenic polypeptide released from activated host blood or 
tissue cells such as macrophages. It is known that the host-derived 
mediator of fever is one of the many activities of IL-1. Gene sequencing 
indicates that what we call IL-1 is probably not a single gene product but 
several distinct polypeptides derived from a multi-gene family. (Duff, 1985) 
The association of fever with the immune response through the 
shared endogenous mediator, IL-1, led to the question of how these two 
effects of IL-1, a brain-mediated elevation in temperature and augmentation 
of lymphocyte activation, might be related. It was found tha t elevated 
temperature has profound effects on the immune system, particularly by 
increasing T-cell proliferation rates, interleukin-l(IL-l)-driven secretion of 
IL-2, and primary antibody responses to T-dependent antigens. To test if the 
pyrogenic action of IL-1 created an optimal temperature environment for its 
own lymphostimulatory action, murine thymocytes were exposed to IL-1 
both at 37°C and at 39°C. T-cell proliferation was measured after three-days 
in culture and was found to be greatly increased at the higher temperature 
(often as much as tenfold). This thermal enhancement of IL-1 driven T-cell 
proliferation did not seem a general property of lymphocyte mitogensis, 
since B cells responded less well to the polyclonal mitogen lipopolysacharide 
at the higher temperature. It was confirmed in vivo that the IL-1 used in 
these experiments was pyrogenic for the mouse strain. Average mouse body 
temperature rose from 37.2°C to 38.59°C following intravenous injection of 
IL-1. (Hanson et al., 1983; Gerne* al., 1991) 
Studies have been performed to test the effect of febrile temperature on 
the primary, in vitro, humoral immune response of murine spleen cells to 
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sheep red blood cells. In this system, a whole population of spleen cells 
responds to the antigenic stimulus by generating activated B cells that 
secrete specific antibody. This phenomenon occurs under T-cell control 
during a five-day culture. Initial experiments showed that the number of 
antibody-producing B cells obtained from these culture could be increased by 
two- to twenty-fold by exposure of the spleen cells to febrile temperatures. 
Furthermore, optimal effects occurred with exposure to hyperthermia 
restricted to the first 24 hours of culture. In contrast, when the cells were 
held at 37°C for the first 48 hours and then exposed to hyperthermia for the 
subsequent three days, no thermal augmentation was detected. When 
individual populations of lymphocytes were exposed to hyperthermia and 
then added back to reconstitute the whole spleen cell culture, it was shown 
that the generation of T-helper cells was greatly increased at the higher 
temperature, while B cell function was not influenced. (Duff, 1985) 
The above results suggest that fever may have survival value through 
increased immune responsiveness at higher temperatures. However, it is 
impor tant to stress tha t the na tura l killer cell activity of human 
mononuclear cells incubated for 18 hours at 39°C was significantly reduced, 
as was the production of IL-1, IL-2, and Granulocyte-macrophage colony-
stimulating factor (GMCS) (Lederman et al., 1987). 
Therapeutic effects of elevated environmental temperature during T. cruzi 
infection 
The therapeutic effect of increased environmental temperature on T. 
cruzi infection in mammals has been described by several investigators; 
however, the precise mechanisms responsible for this phenomenon have not 
been elucidated. 
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In these early studies, mice or rats held at higher temperatures (35 to 
37°C) experienced less intense infections with T. cruzi as indicated by 
decreased parasitemias and increased longevity (Marinkelle & Rodriguez, 
1968). Anderson and Kuhn (1989) provided fur ther evidence for the 
therapeutic effects of increased environmental temperature on T. cruzi 
infection when they reported that C3H mice infected with T cruzi and 
maintained at 36°C experienced both lower parasitemia levels and greater 
longevity than did infected mice held at room temperature. The peak mean 
parasitemia of infected mice held at room temperature was 19- to 20-fold 
greater than that of infected mice held at 36°C. In addition, all infected mice 
maintained at room temperature died by day 38, whereas infected mice 
maintained at 36°C survived throughout the course of the experiment. 
Possible effects of increased temperature on parasites may include 
morphological changes or change in the production of heat-inducible 
parasite proteins. However, Dimock et al (1991) demonstrated that elevated 
temperature does not affect the parasites directly. In this experiment, mice 
held a t 36°C were t rea ted with the immunosuppress ive agent 
cyclophosphamide. Peak mean parasitemia levels were 8.6-fold greater 
than those of non-cyclophosphamide-treated mice held at 36°C, and the 
cyclophosphamide-treated mice all died by day 31 of infection. In a similar 
study, Otieno (1972 and 1973) also found that cyclophosphamide treatment of 
Trypanosoma brucei -infected mice held at 35°C abrogated the beneficial 
effects of elevated environmental temperature. Further support for the 
conclusion that the positive effects of elevated environmental temperature 
are not due to detrimental effects of temperature on the parasite was also 
provided in a report by Dimock et al (1991). These investigators found that 
protection observed in T. cruzi - infected mice held at 36°C could be conferred 
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on infected mice held at room temperature by passive t ransfer of 
hyperimmune sera. 
The ability of T. cruzi - infected mice to produce antibody to 
heterologous antigen has been reported to be enhanced at elevated 
temperatures both in vitro and in vivo in T. cruzi -infected mice. The 
parasite-specific response of T-helper cells in T. cruzi -infected mice held at 
36°C is also enhanced (Dimock et al., 1991). However, Dimock et al (1991) 
reported that production of parasite-specific antibodies is not enhanced early 
in infection. By examining the production of parasite-specific antibodies 
during the acute phase of infection in C3HeB/FeJ mice held at 36°C and at 
room temperature, the authors found that the reactivity and diversity of 
anti-T. cruzi antibodies were greater in mice held at room temperature 
than in those held at 36°C. However, the levels of parasite-specific 
antibodies in infected mice held at 36°C could be elevated to levels which 
surpassed those of infected mice held at room temperature in both reactivity 
and diversity following injection of mice with culture forms of T. cruzi. 
Further analysis of the humoral response to T. cruzi in mice maintained at 
elevated environmental temperature showed that the low levels of parasite-
specific antibodies observed in infected mice held at 36°C may be due to 
lowered antigen exposure as a result of lower parasitemia levels. In their 
experiments, infected mice held at 36°C were capable of mounting a 
stronger anti-T. cruzi antibody response than infected mice held at room 
temperature. Injection of 108 CFs greatly increased both the reactivity and 
diversity of anti-T. cruzi antibodies produced in mice held at 36°C. By using 
enzyme-linked immunosorbent assay and immunoblot analysis, Dimock et 
al (1992) found that both parasite-specific antibody levels and numbers of 
antigens identified increased during infection in mice held at 36°C, with the 
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greatest reactivity measured in sera from mice tha t had resolved 
parasitemias. 
Heat shock of culture forms of T. cruzi resulted in production of heat 
inducible antigens, but there were no strong differences in the antigens 
recognized by sera from mice held at room tempera ture and those 
recognized by sera from mice held at 36°C. However, immunoblot analysis 
using blood-form trypomastigote antigens identified a band of approximated 
61 KD produced by trypomastigotes in mice held at 36°C that was strongly 
detected by sera from mice held at 36°C (Dimock et al., 1992). 
Elevated temperature is known to have profound effects on the 
immune system particularly by increasing T cell proliferation rates, 
enhancing interleukin-l(IL-l) driven secretion of interleukin-2 (IL-2), and 
enhancement of the primary antibody response to T-dependent antigen 
(Gern et al., 1991). Recently, elevated temperature has also been shown to be 
a powerful promoter of IL-1 and IL-2 transcription. However, little 
information is available concerning the precise mechanisms by which 
elevated temperature exerts its effects upon the immune system. 
From the evidence described above, it is clear tha t elevated 
temperature has profound effects on the immune system. In the present 
study, the role of CD4+ T cells in the immune response to T. cruzi in mice 
held at elevated environmental temperature was examined by depletion of 
CD4+ T cells with an murine anti-CD4 monoclonal antibody. 
MATERIALS AND METHODS 
Parasites 
The parasites used in this study were of the Brazil strain of T. cruzi. 
These parasites were maintained in the laboratory as stock infections in 
C3HeB/FeJ mice (BFT, blood-form trypomastigotes). Mice were infected 
intraperitoneally with 103 BFTs in 0.2ml of Dulbecco's phosphate-buffered 
saline (DPBS; GIBCO Laboratories, Grand Island, New York). 
Mice 
Female C3HeB/FeJ mice (Jackson Laboratory, Bar Harbor, Maine) 8-
10 weeks old at the time of infection were used in this study. After infection, 
mice were maintained at room tempera ture or were placed in an 
environmental chamber and held at 36°C. Age-matched groups of non-
infected mice were also held at either room temperature or 36°C for the 
course of experiments. Food and water were provided ad libitum. All mice 
were maintained and used in accordance with local IACUC guidelines. 
Cell Cultures 
The GK1.5 rat hybridoma cell line was purchased from the American 
Type Culture Collection (ATCC; Rockville, MD) and maintained in RPMI-
1640 (Sigma Chemical Co., St. Louis, MO) adjusted to p H 7.2 with 25mM 
Hepes and supplemented with penicillin G (100 units/ml), streptromycin 
(lOOmg/ml) (incomplete RPMI-1640) and 20% fetal bovine serum (FBS) 
(complete RPMI-1640). Cells were grown in 75 cm2 flasks (Corning Glass 
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Co., Corning, NY) and were maintained at 37°C in a 5% CO2 atmosphere at 
high relative humidity. 
Purification Of Anti-CD4 Monoclonal Antibody 
Ammonium Sulfate Precipitation 
Hybridoma (GK1.5) cells were removed from culture supernatants by 
centrifugation at 1300xg for 10 minutes. The supernatants were collected 
and then placed in a large beaker on ice. A 30 cc syringe was used to slowly 
add saturated ammonium sulfate solution to the beaker dropwise while the 
solution was being stirred. The solution was then incubated in the 
refrigerator overnight. Following the overnight incubation, the solution was 
centrifuged at 45,000xg for 1 hour. Supernatant was discarded and the pellet 
was dissolved in 5ml of phosphate buffered saline (PBS). The dissolved 
precipitate was then transfered to dialysis tubing. The antibody solution was 
then dialyzed against a large volume of PBS 24 to 48 hour at 4°C. The buffer 
was changed at least once during dialysis. 
Purification of Rat IgG Using Protein G Affinity Chromatography 
Immobilized protein G gel (BioRad, Richmond, CA) was carefully 
packed into a column according to manufacturer ' s instructions. The 
column was then equilibrated with 10 column volumes of binding buffer (0.1 
M sodium acetate, pH 5.0). The antibody sample was diluted 10:1 with 
binding buffer and then applied to the equilibrated column. The sample was 
allowed to flow completely into the gel. The protein G column was then 
washed with 6-10 column volumes of the binding buffer. The bound IgG was 
eluted with 3-5 volumes of the elution buffer (50mM glycine HC1 buffer, pH 
2.5-2.8). The eluate was collected in 1ml fractions. The pH of the protein 
fractions was returned to neutrality by the addition of 10ml of 500mM Tris 
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buffer, pH 7.6 to each 1ml fraction. The concentration of the antibody was 
determined by the BioRad modification of the Bradford technique (Bradford, 
1976). 
In vivo Depletion of CD4-Specific T cells 
The in vivo depletion of CD4+ T cells was performed according to the 
following technique which was adapted from the method of Kruisbeek (1991). 
Purified anti-CD4 monoclonal antibody from GK1.5 hybridoma culture 
supernatants (380mg) was injected intraperitoneally into individual 8 week 
old mice for three consecutive days. Control mice were injected with an 
equivalent concentration of normal rat IgG. On day 6, spleen cells from one 
mouse from each group were analyzed by indirect immunofluorescence 
followed by direct cell counting with a hemocytometer on an Olympus BH-2-
RF1 fluorescence microscope to determine if satisfactory depletion (>95%) 
had been obtained. (The total number of cells and the number of positive 
cells in four large squares of the hemocytometer was counted and the 
average number of positive cells in one large square was calculated). When 
antibody treatment was judged to have been successful, the mice were 
infected with 103 blood-form trypomastigotes (BFTs) of T. cruzi and were 
immediately placed at either room temperature or 36°C as described above. 
To maintain the depleted condition, remaining mice were given 380mg 
injections of monoclonal antibody every 6-7 days. Two weeks following 
infection, the antibody injections were discontinued. Two mice from each 
group were killed on day 31 of infection to observe the effect of depletion 
during T. cruzi infection. 
The effect of the depletion of CD4+ T cells on the remaining 
population of CD8+ T cells during T. cruzi infection was also determined by 
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comparing the percentage of CD8+ T cells before depletion to the percentage 
following depletion (30 days after T. cruzi infection). In addition, the effect of 
elevated temperature on CD4+ T cell and CD8+ T cell populations following 
CD4+ T cell depletion was also measured. 
Indirect Immunoflourescence Assay 
Preparation of Spleen Cells 
The spleens were surgically removed and placed into small petri 
dishes containing RPMI-1640. The spleens were minced with large forceps 
and the resulting cell suspensions were drawn up into a 5cc syringe 
through 22 gauge needle and expelled into a 15cc tube through a 26 gauge 
needle. Erythrocytes were lysed by hypotonic shock and spleen cells were 
counted with the use of a hemocytometer. The cells were then diluted to a 
final density of l¥107/ml in complete RPMI-1640. 
Indirect Immunofluorescence 
A 100ml aliquot of the spleen cell suspension was placed into a 
microcentrifuge tube on ice. Twenty-five ml (~0.6mg/ml) of purified anti-
CD4+ monoclonal antibody or normal rat IgG (Sigma) were added to the 
contents of the the tube and the tube was mixed well. The cells were 
incubated for 30 min on ice with frequent agitation. The cells were 
centrifuged at 8000xg for 1 minute in a refrigerated microcentrifuge, and 
the supernatant was carefully removed. The cell suspension was washed 
three times with 500ml incomplete RPMI-1640. The cells were resuspended 
inlOOml cold incomplete RPMI-1640 and 5 ml of goat anti-Rat IgG labeled 
with fluorescein isothiocyanate (FITC) was added to the tube. The contents 
of the tube were mixed well and incubated on ice for 30 minutes. The cells 
were centrifuged for 1 min. at 8000x g. The supernatant was removed, and 
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the cells were washed 3 times in 500ml cold incomplete RPMI-1640. After 
the final wash, the cells were resuspended in 100ml of PBS and the results 
analyzed with the use of an Olympus BH-2-RF1 fluorescent microscope. 
Parasitemia and Longevity 
Parasitemia levels were monitored in all infected mice beginning at 
day 12 and continuing every 3 days throughout the course of infection. A 4ml 
sample of blood was taken from the tail, and a dilution of the sample in PBS 
was counted by use of a hemecytometer. In addition, mice were monitored 
daily to determine levels of mortality and morbidity. 
Experimental Design 
The mice were divided into 8 groups according to different 
experimental treatment. Group 1, 2, and 5 had 6 mice in each group. Group 
3, 4, 7, and 8 had 4 mice in each group. The specific experimental treatment 
of each group is shown in Table 1. 
2 3 
Table 1: Experimental Treatment for Each Group of Mice 
CD4+ T cell Temperature Infection 
Group 1 Depleted Room T. cruzi 
Group 2 Non-depleted Room T. cruzi 
Group 3 Depleted Room Normal 
Group 4 Non-depleted Room Normal 
Group 5 Depleted 36°C T. cruzi 
Group 6 Non-depleted 36°C T. cruzi 
Group 7 Depleted 36°C Normal 
Group 8 Non-depleted 36°C Normal 
RESULTS 
The effects of temperature on parasitemia 
The parasitemia levels which were determined for all groups of infected 
mice are shown in Figures 1 through 4. In comparing the parasitemias of mice 
held at 36°C to those held at room temperature, it is clear that maintenance at 36°C 
results in a significant delay in the appearance of blood-form trypomastigotes. The 
parasites appear on day 14 of infection in CD4 depleted mice maintained at room 
temperature and on day 25 in CD4 depleted mice maintained at 36°C. In the CD4 
non-depleted mice, parasites appeared on day 18 in mice held at room temperature 
as compared to day 29 in mice maintained at 36°C. 
In both CD4 depleted and CD4 non-depleted mice, the peaks of parasitemia 
were markedly different between mice maintained at room temperature and 36°C. 
The highest parasitemia levels in room temperature CD4 depleted mice were 1.84 
xlO7 BFT/ml as compared to 9.13 xlO6 BFT/ml in CD4 depleted mice maintained at 
36°C. In CD4 non-depleted mice, the highest parasitemia levels were 1.68 x 107 
BFT/ ml in room temperature CD4 non-depleted mice and 4.37 xlO6 BFT/ml in CD4 
non-depleted mice maintained at 36°C. Obviously, elevated temperature can 
significantly depress the parasitemia in mice infected with T. cruzi. 
Figure 1. The parasitemia in CD4+ T cell depleted mice maintained at room 
temperature (RTLD). Depletion was maintained for 2 weeks of infection. 
Mouse 3 and mouse 5 were killed on day 31 of infection for spleen cell assay. 
Mouse 4 died on day 30. Mouse 2, 6, and 7 died on day 33 of infection. Mouse 
1 died on day 35 of infection. 
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Figure 2. Parasitemia in CD4+ T cell non-depleted mice maintained at 
room temperature ( RTI/ND). Mouse 2 and mouse 4 were killed on day 31 of 
infection for spleen cell assay. Mouse 5 and 7 died on day 33 of infection. 
Mouse 1 died on day 36 of infection. Mouse 3 died on day 39 of infection. 
Mouse 6 died on day 43 of infection. 
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Figure 3. Parasitemia in CD4+ T cell depleted mice maintained at 36°C 
(36I/D). Depletion was maintained for two weeks of infection. Mouse 1 and 
mouse 2 were killed for spleen cell assay on day 31 of infection. Mouse 3 died 
on day 46 of infection and mouse 4 died on day 52 of infection. Mouse 5 
survive through day 52 of infection at which time the experiment was 
terminated. 
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Figure 4. Parasitemia in CD4+ T cell non-depleted mice maintained at 36°C 
(36I/ND). Mouse 3 and mouse 6 were killed on day 31 of infection for spleen 
cell assay. Other mice survived through day 52 of infection at which time 
the experiment was terminated. 
2 8 
Days After Infection 
2 9 
Effects of CD4+ T cell depletion on parasitemia in mice maintained at 36°C 
or room temperature 
In Figure 1 through Figure 4, it can be seen that the depletion of CD4 
+ T cells can slightly enhance the appearance of blood-form trypomastigotes 
of T. cruzi in mice held at room temperature or 36°C. In the two groups of 
mice maintained at room temperature, the parasites appeared on day 14 of 
infection in CD4 depleted mice and on day 18 of infection in CD4 non-
depleted mice (Figure 1 & Figure 2). In mice maintained at 36°C, parasites 
appeared on day 25 in CD4 depleted mice and day 29 in CD4 non-depleted 
mice (Figure 3 & Figure 4). 
Depletion of CD4 + T cells also resulted in shifts in average 
parasitemia value in mice at both temperatures. The peaks of the mean 
parasitemia in different mice group are as follows: 1.84 X 107 in CD4+ T cell 
depleted mice maintained at room temperature; 8.46 XlO6 in CD4+ T cell 
non-depleted mice maintained at room temperature; 7.88 X 106 in CD4+ T 
cell depleted mice maintained at 36°C; 1.7 X 106 in CD4+ T cell non-depleted 
mice maintained at 36°C (Figure 5). The observed peak parasitemia values 
from different group were as follows: in room temperature mice, the peak 
parasitemia in CD4 depleted mice was 1.84 X 107 BFT/ml as compared to 
1.68 X 107 BFT/ml in CD4 non-depleted mice (Figure 1 & Figure 2). In mice 
maintained at 36°C, the peak parasitemia was 9.13 XlO6 BFT/ml in CD4+ T 
cell depleted groups of mice as compared to 4.37 X 106 BFT/ml in CD4+ T cell 
non-depleted mice (Figure 3 & Figure 4). 
Figure 5. Comparison of the mean parasitemia values. RTI/D refers to CD4 
depleted mice infected with T. cruzi maintained at room temperature. 
RTI/ND refers to CD4 non-depleted mice infected with T. cruzi maintained 
at room temperature. 36I/D refers to CD4 depleted mice infected with T. 
cruzi maintained at 36°C. 36I/ND refers to CD4 non-depleted mice infected 
with T. cruzi maintained at 36°C. 
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Effects of CD4+ T cell depletion on mortality in Mice infected with T. cruzi 
Figure 6 shows the mortality data for all four groups of mice infected 
with T. cruzi as compared to non-infected controls. The CD4 depleted mice 
maintained at room temperature (RTI/D) began to die on day 30 of infection, 
and the last mouse died on day 35 of infection. The CD4 non-depleted mice 
maintained at room temperature (RTI/ND) began to die on day 33 of 
infection, and the last mouse died on day 43. CD4 depleted mice maintained 
at 36°C (36I/D) began to die on day 46 of infection, and one mouse survived 
until day 52 of infection. The CD4 non-depleted mice (36I/ND) maintained at 
36°C showed 100% survival through day 50 of infection. 
The results demonstrated that the depletion of CD4+ T cells can shorten the 
life span of infected mice. The life span of CD4 depleted mice held at room 
temperature (RTI/D) was 32.6 ± 1.51 days as compared to 36.8 ± 4.26 in CD4 
non-depleted mice at room temperature (RTI/ND). The life span of CD4 
depleted mice maintained at 36°C (36I/D) was 48 ± 6.6 days. The CD4 non-
depleted mice maintained at 36°C did begin to die at day 55 of infection. The 
precise explanation for this result is unknown but may be due to the 
significant wasting which was observed in the mice maintained at 36°C. 
Mortality in this group was monitored, and the mean life span of CD4 non-
depleted mice maintained at 36°C (36I/ND) was 68 ± 3.1 days. 
Figure 6. Effect of CD4+ T cell depletion on mortality. Controls refer to non-
infected mice maintained at 36°C or room temperature. RTI/D refers to 
CD4 depleted mice infected with T. cruzi maintained at room temperature. 
RTI/ND refers to CD4 non-depleted mice infected with T. cruzi maintained 
at room temperature. 36I/D refers to CD4 depleted mice infected with T. 
cruzi maintained at 36°C. 36I/ND refers to CD4 non-depleted mice infected 
with T. cruzi maintained at 36°C. 
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Results of Depletion Assays 
A depletion assay was performed after the three injections of anti-CD4 
monoclonal antibody. The depletion resul ts obtained by indirect 
immunofluorescence are shown in Figure 7. A comparison of the 
percentage of CD4+ T cells in mice injected with anti-CD4 monoclonal 
antibody to untreated normal mice indicated that > 95% depletion was 
achieved. 
Once 95% depletion was achieved, mice were divided into 8 groups. 
Mice in four of these groups were infected with T. cruzi. Two weeks post-
infection, anti-CD4 monoclonal antibody treatment and normal rat IgG 
treatment were stopped, allowing the CD4+ T cells to gradually replenish. 
Thirty-one days after infection, a second spleen cell assay was performed on 
two mice from each group. The results are shown in Table 2, and Figure 8. 
In this assay, it was found that elevated temperature enhanced the rate of 
replenishment of CD4+ T cells without resulting in a change the percentage 
of CD8+ T cells. 
Furthermore, it was found that the percentage of CD4+ T cells in 
infected mice maintained at 36°C (36I/D) was higher than in mice 
maintained at room temperature (RTI/D). There were 25.63% CD4+ cells in 
36°C mice as compared to 14.67% CD4+ T cells in room temperature mice. 
In non-infected mice, the percentage of CD4+ T cells in CD4 depleted 
mice maintained at 36°C also was higher than in mice maintained at room 
temperature (27.86% CD4 positive cells in 36°C mice; 17.47% CD4 positive 
cells in room temperature mice). (Refer to groups RTNI/D & 36NI/D in Table 
2 and Figure 8) 
It was found that the percentage of CD4 + T cells in CD4 non-depleted 
mice was very similar in infected mice maintained at 36°C and in infected 
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mice maintained at room temperature (Refer to groups RTI/ND & 36I/ND in 
Table 2 and Figure 8). 
Infection also appeared to stimulate the recovery of CD4+ T cells. In 
all group comparisons, (group RTI/D vs group RTNI/D and group 36I/D vs 
group 36NI/D) CD4+ T cells in infected mice recovered faster than CD4+ T 
cells in non-infected mice at both temperatures. 
The CD8+ T cell population was apparently not changed by CD4 
depletion. In addition, there was no evidence that elevated temperature had 
an influence on the percentage of CD8+ T cells in experimental mice. 
Table 2. Spleen Cell Assay. 
Group 1(RTI/D): CD4 depleted mice infected with T. cruzi maintained at 
room temperature. 
Group 2(RTI/ND): CD4 non-depleted mice infected with T. cruzi 
maintained at room temperature. 
Group 3(RTNI/D): CD4 depleted mice non-infected maintained at room 
temperature. 
Group 4(RTNI/ND): CD4 non-depleted and non-infected mice maintained at 
room temperature. 
Group 5(36I/D): CD4 depleted Mice infected with T. cruzi maintained at 
36°C. 
Group 6(36I/ND): CD4 non-depleted mice infected with T. cruzi maintained 
at 36°C. 
Group 7(36NI/D): CD4 depleted mice non-infected maintained at 36°C. 
Group 8(36NI/ND): CD4 non-depleted and non-infected mice maintained at 
36°C. 
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Table 2. Spleen Cell Assay. 
CD4+ T cell (%) CD8+ T cell (%) 
Group 1 (RTI/D) 10.32 16.6 
Group 2 (RTI/ND) 26.05 15.815 
Group 3 (RTNI/D) 11.94 19.91 
Group 4 (RTNI/ND) 26.435 19.91 
Group 5 (36I/D) 19.765 25.925 
Group 6 (36I/ND) 20.835 16.8 
Group 7 (36NI/D) 19.71 17.955 
Group 8 (36NI/ND) 19.685 16.63 
Figure 7. Spleen T cell assay after injection with anti-CD4 antibody. A 
comparison of the percentage of CD4+ T cells in mice injected with anti-
CD4 antibody and in normal mice indicates approximately 95% depletion in 
treated mice. The percentage of CD4+ T cells was determined by an indirect 
immunofluorescence assay followed by direct cell counting with a 
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Figure 8. Analysis of T cell subpopulations by indirect 
immunofluorescence. RTI/D refers to CD4 depleted mice infected with T. 
cruzi maintained at room temperature. RTI/ND refers to CD4 non-depleted 
mice infected with T. cruzi maintained at room temperature. RTNI/D 
refers to CD4 depleted mice non-infected maintained at room temperature. 
RTNI/ND refers to CD4 non-depleted and non-infected mice maintained at 
room temperature. 36I/D refers to CD4 depleted mice infected with T. cruzi 
maintained at 36°C. 36I/ND refers to CD4 non-depleted mice infected with 
T. cruzi maintained at 36°C. 36NI/D refers to CD4 depleted mice non-
infected maintained at 36°C. 36NI/ND refers to CD4 non-depleted and non-
infected mice maintained at 36°C. Percentage refers to % of total spleen 
cells. 









B ID H 
CO CO CO CO 
CD o CD O Z z ^^ — 
— Z o 




B • • 
33 33 33 
—I —I H 
z — — 




The results of this study demonstrate that elevated temperature can 
significantly delay the appearance of trypomastigote stages of T. cruzi in the 
bloodstream and can decrease parasitemia levels and increase longevity in 
infected mice. These results confirm and extend previous reports that 
elevated environmental temperature can increase the immunity of the 
murine host infected with T. cruzi (Anderson & Kuhn, 1989). 
In a previous study, it was demonstrated that maintenance of T. 
cruzi -infected C3HeB/FeJ mice at 36°C not only increased longevity and 
decreased parasitemia but also significantly enhanced both parasite-specific 
and nonspecific immune responses. Whereas immunosuppression during 
experimental Chagas' disease can be overcome to some degree by a variety of 
means, neither the mechanisms responsible for immunosuppression nor 
those responsible for overcoming suppression are clearly understood 
(Anderson and Kuhn, 1989). Dimock et al (1991) found that C3H mice held at 
room temperature developed high levels of parasite-specific antibodies and 
died, whereas mice held at 36°C developed only low levels of anti-T . cruzi 
antibodies by day 35 of infection yet survived infection. Moreover, by day 35 
of infection (just prior to death in mice held at 
temperature) there were no parasite antigens recognized by sera from mice 
held at 36°C that were not also identified by sera from mice held at room 
t e m p e r a t u r e . It was concluded in th i s s tudy t h a t pa ras i t e -
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specific antibodies do not play a significant role in protective immunity 
during the early stages of infection. In the same study, it was found that T-
helper-cell responses to T. cruzi were also enhanced. It is possible that the 
survival of mice held at 36°C during the acute phase of infection may be 
attributable to cell-mediated responses. Results from the present study 
show that CD4+ T cells are required for the protective effect of elevated 
temperature in T. cruzi infected mice. The in vivo depletion of CD4 + T cells 
advanced the onset of parasitemia approximately 4 days in mice maintained 
at room temperature or 36°C. However, in both CD4 depleted mice and CD4 
non-depleted mice, maintenance at elevated temperature significantly 
delayed the appearance of parasites. This result suggests tha t elevated 
temperature does have some effect upon the parasite which is independent 
of the activity of CD4+ T cells. Because CD4+ T cells play a central 
regulatory function in the immune system, few functional protective 
immune responses should remain after CD4+ T cells have been destroyed. 
In the present study elevated temperature still exerted some protective 
effects even after the depletion of CD4+ T cells. The recovery of CD4+ T cells 
during infection may be part of the explanation, but it is still clear that other 
components of the immune system must contribute to this phenomenon 
through unknown pathways. 
Elevated temperature greatly decreased the parasitemia levels in 
infected mice, but the depletion of CD4+ T cells resulted in slightly increased 
parasitemia levels in mice held at room temperature or 36°C, providing 
further evidence that the beneficial effect of elevated temperature is to some 
degree CD4 + T cell independent. 
Elevated temperature also significantly delayed mortality in infected 
mice. The CD4 depleted mice maintained at 36°C died approximately 12 days 
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later than CD4 depleted mice held at room temperature. All CD4 non-
depleted mice held at room temperature died by day 46 of infection while CD4 
non-depleted mice at 36°C maintained 100% survival until 52 days post-
infection. From these mortality data, it can be hypothesized that CD4+ T 
cells play an important protective role in the early stages of T. cruzi 
infection. Once CD4+ T cells were depleted, the protective immune response 
at elevated temperature was disrupted. Even when the CD4+ T cells were 
allowed to recover at 2 weeks post infection, the mice maintained at elevated 
temperature still died by day 46 of infection. Further studies are needed to 
determine what window of time is crucial for mice to establish and 
maintain a protective response against the parasite. 
The results of the present study suggest the following conclusions: 1) 
Results confirm previous studies demonstrating that elevated temperature 
increases the resistance of mice to T. cruzi. 2) The CD4+ T cell is necessary 
to allow mice to establish and to maintain this temperature related 
resistance to T. cruzi. 3) Enhanced resistance to T. cruzi a t elevated 
temperature also involves CD4+ T cell independent pathways. 4) This in vivo 
experiment confirmed previous in vitro studies indicating that elevated 
temperature increases the rate of proliferation of CD4+ T cells. Because of 
the complex role played by CD4 + T cells in the immune system, it is difficult 
to define the specific role of CD4+ T cells in the beneficial effect of elevated 
temperature during T. cruzi infection. Further experiments will be required 
to fully elucidate the role of CD4+ T cells in this phenomenon. 
Several unexpected results occurred during the course of these 
experiments. Enlarged spleens were found in mice injected with anti-CD4 
monoclonal antibody and normal ra t IgG. This result suggests that mice 
were mounting a significant immune response against the injected ra t 
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immunoglobulin. Repeated injection of the anti-CD4 monoclonal antibody 
resulted in the death of some mice. Similar observations have not been 
mentioned in previous studies. Severe wasting was also seen to occur in 
mice maintained at 36°C. As a consequence, all of the mice died by day 70 of 
infection even though the parasitemia levels fell to zero. The possible 
explanation for this phenomenon could be large quantities of IL-1 or TNF-a 
produced by higher temperature and infection. (Duff, 1985) 
Another unexpected result of this experiment was tha t elevated 
temperature was shown to stimulate the recovery of CD4+ T cells following 
in vivo depletion with monoclonal antibody. Previous studies have shown 
that elevated temperatures can increase the rate of proliferation of CD4+ T 
cells ( Gern et al., 1991). The present study represents in vivo confirmation 
of this phenomenon. 
In conclusion, CD4+ T cells do participate in the enhanced immune 
response to T. cruzi at elevated environment temperature, but the precise 
functional role of CD4+ T cells is not yet known. 
LITERATURE CITED 
Abbas, A.K., Williams, M.E., Burstein, H.J., Chang, T.L., Bossu, P. & 
Lichtman, A. (1991). Activation and functions of CD4+ T cell subsets. 
Immunol. Rev. 123: 5-22. 
Anderson, K.J. & Kuhn, R.E. (1989). Elevated environmental temperature 
enhances immunity in experimental Chagas' disease. Infec. and 
Immun. 57: 13-17. 
Araujo, F.G. (1992). Depletion of CD4+ T cells but not inhibition of the 
protective activity of IFN-y prevents cure of toxoplasmosis mediated by 
drug therapy in mice. J . Immunol. 149: 3003-3007. 
Araujo, F.G. (1991). Depletion of L3T4+(CD4+) T lymphocytes prevents 
development of resistance to Toxoplasma gondii in mice. Infec. and 
Immun. 59: 1614-1619. 
Beaman, M.H., Wong, S.Y., & Remington, J. (1992). Cytokines, toxoplasma 
and intracelluar parasitism. Immunol. Rev. 127: 97-117. 
Bacchetta, R., de Waal Malefijt, R., Yssel, H., Abrams, J., de Vries, J.E., 
Splits, H. & Roncarolo, M.G. (1990). Host-reactive CD4+ and CD8+ T cell 
clones isolated from a human chimera produce IL-5, IL-2, IFN-gamma 
4 2 
4 3 
and granulocyte/macrophage colony-stimulating factor but not IL-4. J . 
Immunol. 144: 902-908. 
Bradford, M. 1976. A rapid and sensitive method for the quantitation of 
microgram quantities of protein utilizing the principle of protein-dye 
binding. Anal. Biochem. 72: 248-254. 
Cher, D.J. & Mosmann, T.R. (1987). Two types of murine helper T-cell 
clones. II.-- Delayed-type hypersensitivity is mediated by TH1 clones. J. 
Immunol., 138: 3688-3694. 
Cherwinski, H.C., Schumacher, J.H., Brown, K.D., Mosmann, T.R. (1987). 
Two types of mouse helper T cell clone: 3. Fur ther differences in 
lymphokine synthesis between TH1 and TH2 clones revealed by RNA 
hybridization, functionally monospecific bioassays and monoclonal 
antibodies. J. Exp. Med. 166: 1229-1244. 
Coffman, R.L. & Mosmann, T.R. (1991). CD4+ T cell subset: regulation of 
differentiation and function. Res. Immunol. 142: 7-8. 
Cox, F.E.G. and Liew, F.Y. (1992). T cell Subsets and Cytokines in Parasitic 
Infections. Immunol.Today 142 (2): 141-143. 
Cunningham, D.S. & Kuhn, R.E. (1980). Trypanosoma cruzi- induced 
suppression of the primary immune responses in murine cell cultures to 
T-cell-dependent and -independent antigens. J . Parasitol. 66(1): 16-23. 
Dimock, K.A., Davis, C.D., and Kuhn, R.E. (1991). Effect of elevated 
environmental temperature on the antibody response of mice to 
4 4 
Trypanosoma cruzi during the acute phase of infection. Infec. and 
Immun. 59:4377-4382. 
Dimock, K.A., Davis, C.D. and Kuhn, R.E. 1992. Changes in the humoral 
response to Trypanosoma cruzi in mice held at elevated temperature. J. 
Parasitol. 78(4): 686-696. 
Duff, G.W. (1985). Is fever beneficial to host: A Clinical perspective. Yale J. 
Bio. Med. 59:125-130. 
Fiorentino, D.F., Bond, M.W. & Mosmann, T.R. (1989). Two types of mouse T 
helper cell. IV.—TH2 clones secrete a factor tha t inhibitors cytokine 
production by TH1 clones. J . Exp. Med. 170: 2081-2095. 
Fiorentino, D.F., Zlotnik, A., Mosmann, T.R. Howard, M. & O'Garra, A. 
(1991b). IL-10 inhibits cytokine production by activated macrophages. J. 
Immunol. 147: 3815-3822. 
Fiorentino, D.F., Zlotnik, A., Mosmann, T.R., Howard, M., Moore, K.W. & 
O'Garra, A. (1991b). IL-10 acts on the antigen-presenting cell to inhibit 
cytokine production by Thl cells. J . Immunol. 146: 3444-3451. 
Gajewski, T.F., Schell, S.R., Nau, G., Fitch, F.W. (1989). Regulation of T cell 
activation: differences among T-cell subsets. Immunol. Rev. I l l : 79-110. 
Gazzinelli, G., Xu, Y. Hieny, S., Cheever, A. & Sher, A. (1992). 
Simultaneous depletion of CD4+ and CD8 + T lymphocytes is required to 
reactivate chronic infection with Toxoplasma gondii . J . Immunol., 149 
(1): 175-180. 
4 5 
Gern, J.E., Jayman, J.R., Goldberg, L. Murphy, P.A. & Lederman, H.M. 
(1991). Tempera ture is a powerful promoter of in te r leukin 2 
transcription. Cytokine 3(5): 389-397. 
Gonzalves da Costa, S.C., Lagrange, P.H., Hurtrel, B., Kerr, I. & Alencar, 
A. (1984). Role of T lymphocytes in the resistance and immunopathology 
of experimental Chagas' disease. Ann. Immunol. (Inst. Pasteur) 135 C: 
317-332. 
Hanson, D.F., Murphy P.A., Silicano, R., & Shin, H.S. (1983). The effect of 
temperature on the activation of the activation of thymocytes by 
interleukins I and II. J . Immunol. 130 (1): 216-221. 
Hontebeyrie-Joskowicz, M. (1991). Murine Trypanosoma cruzi infection: a 
role for TH2 cells in the immunopathology of chronic infection. Res. 
Immunol. 142:141-143. 
Kruisbeek, A.M. (1991). In vivo depletion of CD4 and CD8- specific T cells. 
Curr. Prot. Immunol. 1: 4.1-4.2. 
Kuby, J . (1992). Immunology. W. H. Freeman Company, New York, pp 227. 
Kuhn, R. E. 1981. Immunology of Trypanosoma cruzi infections. In 
Parasitic Diseases. The Immunology. (J. Mansfield, ed.) Marcel Dekker, 
Inc., New York, pp 137-166. 
Kuhn, R.E., Lederman, H.D., Brill, C.R. & Murphy, P.A. (1987). 
Interleukin-1-driven secretion of interleukin 2 is highly temperature-
dependent. J. Immunol. 138: 3808-3815. 
46 
Marinkelle, C.J. & Rodriguez, E. (1968). The influence of environmental 
temperature on the pathogenicity of Trypanosoma cruzi in mice. Exper. 
Parasitol. 23: 260-263. 
Minoprio, P., Itohara, S., Heusser, C., Tonegawa, S., Coutinho, A. (1989). 
Immunobiology of murine T. cruzi infection: the predominance of 
parasite-nonresponses and the activation of TCR1 T cells. Immunol. Rev. 
112:183-207. 
Mosmann, T.R., Cherwinski, H., Bond, M.W., Giedlin, M.A & Coffman, 
R.L. (1986). Two types of murine helper T cell clone. I. Definenition 
according to profiles of lymphokine activities and secreted proteins. J. 
Immunol., 136: 2348-2355. 
Mosmann, T.R. & Moore, K.W. (1991) The role of IL-10 in cross-regulation of 
TH1 and TH2 responses. In Immunoparasitology Today, (Ash, C. & 
Callagher, R. B. ed.). pp A49-A53.. Elsevier Trade Journals, Cambridge. 
Mosmann, T.R. & Coffman, R.L. (1989). TH1 and TH2 cells: different 
patterns of lymphokine secretion lead to different functional property. 
Ann. Rev. Immunol. 7: 145-173. 
Mosmann, T.R., Schumaker, J.H., Street, N.F., Budd,R., O'Garra, A., 
T.A., Bond, M.W., Moore, K.W.M., Sher, A & Fiorentino, D.F. (1991). 
Diversity of cytokine synthesis and function of mouse CD4+ T cells. 
Immunol. Rev. 123: 209-312. 
Al 
Otieno, L.H. (1972). Influence of ambient temperature on the course of 
experimental trypanosomiasis in mice. Ann. Trop. Med. Parasitol. 66: 
15-24. 
Otieno, L.H. (1973). Effects of immunosuppressive agent on the course of 
Trypanosoma (Trypanozoon) brucei infections in heat-stressed mice. 
Trans. R. Soc. Trop. Med. Hyg. 57: 856-868. 
Peltz, G. (1991). A role for CD4+ T cell subsets producing a selective pattern 
of lymphokines in the pathogenesis of human chronic inflammatory and 
allergic diseases. Immunol. Rev. 123: 23-35. 
Plata, F., Garcia-pons, F. & Wietzerbin, J. (1987). Immune resistance to 
Trypanosoma cruzi: synergy of specific antibodies and recombinant 
interferon gamma in vivo. Ann. Immunol. (Inst. Pasteur) 138: 379-415. 
Sadick, M.D., Heinzel, F.P., Holaday, B.J., Pu, R.P., Dawkins, R.S. & 
Locksley, R.M. (1990). Cure of murine leishmaniasis with anti-
Interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, 
Interferon g-independent mechanism. J. Exp. Med. 171: 115-127. 
Scott, P., Pearce, E., Cheever, A.W., Coffman, R.L., Sher, A. (1989). Role of 
cytokines and CD4+ T cell subsets in the regulation of parasite immunity 
and disease. Immunol. Rev. 112: 161-182. 
Scott, P. & Kaufman, S.H.E. (1991). The role of T cell subsets and cytokines 
in the regulation of infection. Immunol. Today 12: 346-348. 
48 
Scott, P. (1991). IFN-gamma modulates the early development of TH1 and 
TH2 responses in a murine model of cutaneous leishmaniasis. J . 
Immunol. 147: 3149-3155. 
Sher, A., Fiorentino, D., Caspar, P., Pearce, E. & Mosmann T.R. (1991). 
Production of IL-10 by CD4+ T lymphocytes correlates with down-
regulation of TH1 cytokine synthesis in helminth infect. J . Immunol. 
147:2713-2716. 
Sher, A. & Coffman, R.L. (1992) Regulation of immunity to parasites by T 
cells and T cell derived cytokines. Ann. Rev. Immunol. 10: 385-409. 
Sher, A., Gazzinelli, R.T., Oswald, I.P., Clerici, M., Kullberg, M, Pearce, 
E.J., Berzofsky, J.A., Mosmann, T.R., James, S.L., Morse III, H.C. and 
Shearer , G.M. (1992). Role of T-cell derived cytokines in the 
downregulation of immune responses in parasit ic and retroviral 
Infection. Immunol. Rev. 127: 183-204. 
Swendel, S., Gonzaga, A.L. (1993). Chagas' disease and blood transfusion: a 
new world problem? Vox Sang 64: 1-12. 
Silva, J.S., Twardzik, D.R. & Reed, S.G. (1991). Regulation of Trypanosoma 
cruzi infections in vivo and in vivo by transforming growth factor b 
(TGF-b). J . Exp. Med. 174: 539-545. 
Tarleton, R. L., & Kuhn, R.E. (1983). Measurement of parasite-site-specific 
immune responses in vivo: evidence for suppression of the antibody 
response to Trypanpsoma cruzi. Eur. J. Immunol. 15: 845-850. 
4 9 
Tarleton, R. L., & Kuhn, R.E. (1985). Measurement of parasite-site-specific 
immune responses in vivo :evidence for suppression of the antibody 
response to Trypanpsoma cruzi. Eur. J . Immunol. 15: 845-850. 
Tarleton, R.L. 1990. Depletion of CD8+ T cells increases susceptibility and 
reverses vaccine-induced immunity in mice infected with Trypanosoma 
cruzi. J . Immunol. 144: 717-724. 
Tarleton, R.L. (1991a). The role of T-cell subpopulations in experimental 
Chagas' disease. Res. Immunol. 142: 130-133. 
Tarleton, R.L. (1991b). Regulation of immunity in Trypanosoma cruzi 
infection. Exp. Parasitol. 73: 106-109. 
Trischman, T.M. (1983). Non-antibody-mediated control of parasitemia in 
acute experimental Chagas' disease. J . Immunol. 130: 1953-1957. 
